Evidence map›Paper›PMID 39638951›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2025

The cerebellar glucose metabolism in moyamoya vasculopathy and its correlation with neurocognitive performance after cerebral revascularization surgery: a [

Ruiyuan Weng, Shuhua Ren, Jiabin Su, Hanqiang Jiang, Heng Yang, Xinjie Gao, Zhiwen Jiang, Yuchao Fei, Yihui Guan, Fang Xie and 3 more

Abstract read
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. The combination of theScientific reports · 2025
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Ruiyuan Weng *Department of Neurosurgery, Huashan Hospital of Fudan University, Shanghai, 200040, P. R. China.
Shuhua Ren *Department of PET Center, Huashan Hospital of Fudan University, Shanghai, 200040, P. R. China.
Jiabin Su *Department of Neurosurgery, Huashan Hospital of Fudan University, Shanghai, 200040, P. R. China.
Hanqiang JiangDepartment of Neurosurgery, Huashan Hospital of Fudan University, Shanghai, 200040, P. R. China.
Heng YangDepartment of Neurosurgery, Huashan Hospital of Fudan University, Shanghai, 200040, P. R. China.
Xinjie GaoDepartment of Neurosurgery, Huashan Hospital of Fudan University, Shanghai, 200040, P. R. China.
Zhiwen JiangDepartment of Neurosurgery, Huashan Hospital of Fudan University, Shanghai, 200040, P. R. China.
Yuchao FeiDepartment of Neurosurgery, Huashan Hospital of Fudan University, Shanghai, 200040, P. R. China.
Yihui GuanDepartment of PET Center, Huashan Hospital of Fudan University, Shanghai, 200040, P. R. China.
Fang XieDepartment of PET Center, Huashan Hospital of Fudan University, Shanghai, 200040, P. R. China.
Wei NiDepartment of Neurosurgery, Huashan Hospital of Fudan University, Shanghai, 200040, P. R. China. hsniwei@fudan.edu.cn.
Qi HuangDepartment of PET Center, Huashan Hospital of Fudan University, Shanghai, 200040, P. R. China. hq_1124@163.com.
Yuxiang GuDepartment of Neurosurgery, Huashan Hospital of Fudan University, Shanghai, 200040, P. R. China. guyuxiang1972@126.com.ORCID 0000-0002-4580-2205

Funding

National Natural Science Foundation of China 82171313National Natural Science Foundation of China 82271338National Natural Science Foundation of China 82301492Shanghai Hospital Development Center SHDC2022CRD032
6 · The paper itself

Abstract

backgroundThe vascular cognitive impairment (VCI) is quite common in moyamoya vasculopathy (MMV). However, the abnormality of cerebellar glucose metabolism in MMV and its relationship with patients' neurocognitive performance were few reported.

objectiveIn this study, we aimed to investigate the relationship between neurocognitive performance and cerebellar glucose metabolism. Furthermore, the cerebellar glucose metabolism changes after combined revascularization surgery were also researched.

methodsWe retrospectively analyzed the 2-[

resultsSUVR of right Lobule VI/Crus II/VIII decreased when cognitive impairment progression (P < 0.05, Least-Significant Difference [LSD] post hoc analysis). The cerebellar glucose metabolic pattern can be divided into two parts, in which the cerebellar posterior lobe was positively related to patients' neurocognitive performance, while the vermis and anterior lobe showed negative relationship with the neurocognitions (P < 0.001). Further MCN analysis expound that the degree of right Lobule VI/Crus II/VIII displayed decreased tendency as cognitive impairment worsened (P < 0.05, LSD post hoc analysis). After revascularization surgery, the SUVR of right cerebellar posterior lobe significantly promoted in improved group (P < 0.001). Besides, we also witnessed the SUVR improvement in left cerebral hemisphere, thalamus, and red nucleus (P < 0.001). The MCN analysis revealed that the posterior connective strength improvement among right Lobule VI and several cerebral regions significantly correlated with memory and executive screening (MES) score (P < 0.001, false discovery rate corrected).

conclusionWe found that the hypometabolism of cerebellar posterior lobe, especially in the right Lobule VI, was associated with MMV patients' neuropsychological performance, while the anterior lobe and vermis showed opposites tendencies. Combined revascularization surgery improved the posterior cerebellar metabolism and was associated with favorable neurocognitive outcomes, which might be related to the activation of cortico-rubral-cerebellar pathway.

Indexed as

CerebellumCerebral RevascularizationCognitionFluorodeoxyglucose F18GlucoseMoyamoya DiseasePositron-Emission TomographyAdultCognitive DysfunctionFemaleHumansMaleMiddle AgedRetrospective StudiesFluorodeoxyglucose F18Glucose[18F]FDG PETCerebellar glucose metabolismCerebral revascularizationCognitive impairmentMoyamoya vasculopathy

Identifiers

PMID39638951
PMCPMC11839855

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.